PALANTIR TECHNOLOGIES INC
Commented by Stefan Feulner on June 10th, 2024 | 07:00 CEST
Infineon, MGI - Media and Games Invest, Palantir - These 3 shares are about to break out
Last week was a tough one. Firstly, the European Central Bank heralded the turnaround in interest rates and, as expected, lowered the key interest rate by 25 basis points to 4.25%. Secondly, the hype surrounding meme stocks, and GameStop in particular, was revived by the comeback of influencer Keith Gill, aka Roaring Kitty. Following a live stream on YouTube, the share price soared again and will likely remain a hot topic over the next few trading days.
Read
Commented by Stefan Feulner on April 9th, 2024 | 06:45 CEST
Palantir, Globex Mining, Bayer - The trend is pointing upwards
After a successful first quarter of 2024, the DAX and Dow Jones took a well-deserved breather last week. In contrast, the precious metal markets for gold and silver continued their upward trend. Gold also reached new absolute highs of USD 2,354 per ounce. While gold producers such as Barrick Gold and Newmont remained in hibernation, they have been following the rising base price for several weeks now. There is currently also an opportunity for smaller commodity stocks to participate disproportionately in the upward trend.
Read
Commented by André Will-Laudien on April 2nd, 2024 | 06:55 CEST
AI shares in takeover frenzy, further gains of over 100% possible with Nvidia, Exasol, Palantir and Super Micro Computer
In the first quarter of 2024, the stock markets were at their friendliest, but the focus was almost exclusively on Bitcoin, Artificial Intelligence and high-tech. Meanwhile, the market leader in fast chips, Nvidia, has become the epicenter of future Big Data and AI applications. Productivity increases of over 20% per year are expected worldwide through the use of artificial intelligence in businesses, but commercial market penetration is still in its infancy. Therefore, it can be assumed that the rally will continue or even accelerate in the current environment. In addition to the well-known crowd-pullers, there are also latecomers with huge potential, including in Germany.
Read
Commented by Armin Schulz on February 13th, 2024 | 07:00 CET
TUI, Globex Mining, Palantir - Movement is possible here
Investors should have TUI, Globex Mining and Palantir on their watchlist, as they could be on the verge of movement. While TUI, as a leading tourism company, is showing signs of recovery after the pandemic, Globex Mining promises important impetus for the future of the industry and green technologies with its broad commodities portfolio. Palantir, on the other hand, known for its advanced data analytics platforms, is on the brink of significant growth opportunities in an increasingly data-rich era. In this context, movements are possible, and as an investor, one would want to be invested early. We highlight the potential of the three companies.
Read
Commented by André Will-Laudien on September 14th, 2023 | 09:05 CEST
Artificial Intelligence in practice? Nvidia, NorCom, Palantir - The next 100% with Big Data
The stock market is not a one-way street. Investors are trying to ride the wave of "Artificial Intelligence" (AI), and corresponding stocks such as C3.ai, Nvidia, Microsoft, or Palantir are performing well in 2023. A new megatrend is underway here, which, according to experts, will continue for several years. However, because of the high valuations in the entire sector, it is worth taking an analytical look. After all, no one knows how long the AI boom will continue to generate decent returns on the stock market. Opportunity-rich stocks still exist in the second and third tier. We are taking a closer look.
Read
Commented by Juliane Zielonka on August 24th, 2023 | 07:00 CEST
Defence Therapeutics, Bayer, Palantir - Milestones, Power Shifts and Mishmash
The radiopharmaceuticals market is expected to grow to USD 13.818 billion by 2028. In collaboration with Orano Group, Defence Therapeutics has developed innovative radioactive cancer therapies that destroy cancer at the cellular level, thereby increasing efficacy and minimizing side effects. According to Defence Therapeutics CEO Sebastien Plouffe, this partnership will lead to top-tier therapies in a growing market. Meanwhile, heads are rolling at Bayer, as CEO Bill Anderson has big plans and is replacing key positions with promising candidates. Employees of the British NHS have probably spoken a bit too much. The US company Palantir has been awarded five NHS contracts without competitive bidding and is currently the favorite for a multi-million dollar contract in the healthcare sector. Find out what this means for investors here.
Read
Commented by Stefan Feulner on August 10th, 2023 | 08:30 CEST
Palantir, First Phosphate, E.ON - A decade of growth
The climate transition requires significant investments in energy infrastructure, which should benefit companies like the utility provider E.ON well beyond the current decade. Another beneficiary of this transformation are producers of the raw materials needed for the energy transition, for which demand already exceeds scarce supply in some areas.
Read
Commented by André Will-Laudien on August 2nd, 2023 | 09:05 CEST
Artificial Intelligence - Now it is really taking off! Palantir, Lufthansa, TUI, Viva Gold - These shares are on the rise!
After extensive climate blockades at the airports in Hamburg, Düsseldorf and Munich, the environment minister of the Green Party, Robert Habeck, also spoke out: "The activists, who are now obstructing people from traveling on vacation, are doing massive damage to the cause of climate protection." Quite right! They also significantly disrupt traffic and cause considerable economic costs due to delays and cancellations. This could soon come to an end as the affected airport operators are filing criminal complaints. If real sanctions with imprisonment are finally imposed, the issue could be effectively addressed, and the government can demonstrate its ability to act anew. After all, many citizens now have doubts about the implementation of important public objectives, for which an expensive state apparatus is now responsible. What should investors pay attention to?
Read
Commented by Stefan Feulner on July 31st, 2023 | 09:50 CEST
BASF, Cantourage Group, Palantir - Now the analysts speak out
Currently, it is high noon for the release of first-half 2023 earnings. Despite all the uncertainties regarding geopolitical and fiscal policy, the majority of companies surprised positively. As a result, the Dow Jones, DAX, Nasdaq and others were able to climb to new highs for the year. Analysts also see further upside potential for many companies, which could accelerate the rally in the coming weeks.
Read
Commented by Juliane Zielonka on July 21st, 2023 | 07:20 CEST
BioNxt Solutions, Morphosys, Palantir - Innovative therapies for Parkinson's, cancer and soaring with AI
There are exciting developments in the biotech industry. Thanks to innovative AI technologies, companies like BioNxt Solutions bionxt.com/investors can analyze medical data faster and develop an innovative medical patch that provides Parkinson's patients with faster symptom relief. This patch carries the active ingredient rotigotine and has enormous market opportunities worldwide. Blockbuster-level market opportunities are emerging at Morphosys with regard to its compound pelabresib for the treatment of a rare form of blood cancer. The Phase III trial is expected to deliver results earlier than expected, and analysts see promising opportunities for the drug. According to a study by Bristol Myers Squibb, about 1.85 million new cases of blood cancer are expected worldwide in 2040. Deutsche Bank rated the stock "hold," driving the price up 4.9% this week. Also pushing upward is Palantir. The US company is getting into the drone business thanks to a partnership with Canada's Airmatrix.
Read